Premium
Pindolol (Viscén®) in Persistent Ventricular Fibrillation
Author(s) -
Holmboe J.,
Lilleásen P.,
Normann E.
Publication year - 1976
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1976.tb05011.x
Subject(s) - medicine , defibrillation , pindolol , ventricular fibrillation , sinus rhythm , lidocaine , anesthesia , cardiology , tachycardia , resuscitation , ventricular tachycardia , shock (circulatory) , fibrillation , electrotherapy , atrial fibrillation , propranolol , alternative medicine , pathology
The beneficial effect of a beta‐blocking agent (pindolol), given as an adjuvant to DC‐shock and lidocaine therapy in a case of heart resuscitation is reported. A 65‐year‐old female patient was operated for an abdominal aortic aneurysm. At the conclusion of the operation, which was prolonged and difficult, the patient developed alternating ventricular tachycardia and fibrillation. Within a time interval of 50 min electrical defibrillation was performed 20 to 25 times, and as much as 1100 mg of lidocaine was administered. Simultaneously, combined internal/external cardiac massage was performed. The patient's arrhythmia continued to recur after defibrillation until pindolol in dosages of 0.2 mg had been given twice intravenously. A permanent sinus rhythm was then achieved.